Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients

Conditions: Genetic Polymorphisms; Heart Failure Interventions: Drug: SGLT2 inhibitors (Dapagliflozin and Empagliflozin) Sponsors: October 6 University; University of Florida; National Heart Institute, Egypt; Beni-Suef University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials